Table 2.
Diagnostic performance of TE and SWE-10, SWE-5, or SWE-3 for the diagnosis of significant (F2-F4) and advanced fibrosis (F3-F4)
| AUROC | 95% CI | P-value | |
|---|---|---|---|
| Significant fibrosis | |||
| TE | 0.719 | 0.572-0.867 | 0.016 |
| SWE-10 | 0.787 | 0.646-0.927 | 0.002 |
| SWE-5 | 0.809 | 0.676-0.942 | 0.001 |
| SWE-3 | 0.714 | 0.560-0.869 | 0.021 |
| P-value | 0.301 | ||
| Advanced fibrosis | |||
| TE | 0.799 | 0.646-0.952 | <0.001 |
| SWE-10 | 0.797 | 0.659-0.935 | <0.001 |
| SWE-5 | 0.809 | 0.684-0.933 | <0.001 |
| SWE-3 | 0.736 | 0.587-0.885 | 0.003 |
| P-value | 0.496 |
TE, transient elastography; SWE-10, p-SWE with 10 measurements; SWE-5, p-SWE with five measurements; SWE-3, p-SWE with three measurements; p-SWE, point shear-wave elastography; AUROC, area under the receiving operator characteristic curve; CI, confidence interval.